Must we endure excessive drug prices to encourage pharmaceutical R&D?
A mechanism of funding pharmaceutical research which leads to drug prices far in excess of marginal cost is bound to lead to anguish and injustice. But is there a better idea?
Must we endure excessive drug prices to encourage pharmaceutical R&D? Read More »
